Windgap Medical, ALK partner to commercialise epinephrine autoinjector
The partnership allows ALK to gain exclusive, worldwide sales and distribution rights for the Windgap EAI
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Aug 19
The partnership allows ALK to gain exclusive, worldwide sales and distribution rights for the Windgap EAI
08 Aug 19
NuLids, simple one-minute, once-a-day, doctor directed at-home treatment for dry eye disease, can significantly improve both the signs…
02 Aug 19
Rakuten Medical intends to use the capital to develop its oncology-focused PIT platform, strengthen its business and commercial…
31 Jul 19
Under the agreement the Gofire Inhaler and SMART Cartridges will become available to patients using concentrates in Australia…
26 Jul 19
AptarGroup, a provider of dispensing and drug delivery solutions, has secured approval from the US Food and Drug…
25 Jul 19
Breath Therapeutics' inhalation drug aims to be the first-in-class therapy for Bronchiolitis Obliterans Syndrome approved by the FDA
NorthStar Medical Radioisotopes, a producer and distributor of radioisotopes for medical imaging, has secured $15m (£12m) funding in…
Glaukos, an ophthalmic medical technology company, has signed a licensing agreement with Intratus, for a drug delivery platform…
22 Jul 19
The Ugandan government will support blockchain company MediConnect to explore using its technology to tackle the spread of…
Pear Therapeutics is seeking an approval from the US Food and Drug Administration (FDA) for its prescription digital…